Posted: April 30th, 2020
Biolitec Pharma Marketing Ltd. v. Tobrix B.V., District Court The Hague, The Netherlands 15 April 2020, Case No. ECLI:NL:RBDHA:2020:3414
Biolitic develops and produces medical laser systems and optical fibres and holds EP 2 620 119 B1 relating to an ‘Endoluminal laser ablation device for treating veins’. Biolitic accused Tobrix of patent infringement.
The patent is revoked in part due to lack of inventive step. As Biolitec invoked only the now revoked claims in the infringement action, an injunction is denied.